You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Polycythemia Vera (PV)

Showing 1 - 25 of 631
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Polycythemia Vera (PV) Trial in Japan (P1101, Low-dose aspirin, Phlebotomy)

Not yet recruiting
  • Polycythemia Vera (PV)
  • Mie, Japan
  • +5 more
Aug 15, 2023

Polycythemia Vera Trial (bomedemstat)

Not yet recruiting
  • Polycythemia Vera
  • (no location specified)
Oct 24, 2022

QoL and Symptoms in Polycythemia Vera Receiving Ruxo inRoutine

Not yet recruiting
  • Polycythemia Vera
  • (no location specified)
Sep 30, 2022

Polycythemia Vera Trial (Ropeginterferon alfa-2b-njft (P1101))

Not yet recruiting
  • Polycythemia Vera
  • Ropeginterferon alfa-2b-njft (P1101)
  • (no location specified)
Jul 28, 2022

Polycythemia Vera Trial (Hydroxyurea)

Not yet recruiting
  • Polycythemia Vera
  • (no location specified)
May 2, 2023

Polycythemia Vera Trial (Givinostat Hydrochloride, Hydroxy Urea)

Not yet recruiting
  • Polycythemia Vera
  • Givinostat Hydrochloride
  • Hydroxy Urea
  • (no location specified)
Oct 19, 2023

Ruxolitinib for Polycythemia Vera in Patients Resistant to or

Completed
  • Polycythemia Vera (PV)
  • Ruxolitinib
  • East Hanover, New Jersey
    Novartis Investigative Site
Jun 29, 2022

Polycythemia Vera Trial in Tianjin (Ruxolitinib, Pegylated interferon a-2b)

Recruiting
  • Polycythemia Vera
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
May 19, 2023

Polycythemia Vera Trial (Ruxolitinib)

Available
  • Polycythemia Vera
  • (no location specified)
Mar 7, 2022

Polycythemia Vera (PV) Trial in Japan (P1101 (Ropeginterferon alfa-2b))

Recruiting
  • Polycythemia Vera (PV)
  • P1101 (Ropeginterferon alfa-2b)
  • Toon-shi, Ehime, Japan
  • +5 more
Jun 13, 2022

Myelofibrosis (PMF), Post Essential Thrombocythemia Myelofibrosis (ET-MF), Post Polycythemia Vera Related Myelofibrosis (PV-MF)

Not yet recruiting
  • Myelofibrosis (PMF)
  • +2 more
  • New York, New York
    Ruttenberg Treatment Center
Apr 18, 2023

Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), Post-Essential Thrombocythemia Myelofibrosis

Terminated
  • Primary Myelofibrosis (PMF)
  • +2 more
  • Larkspur, California
  • +2 more
Nov 14, 2022

Polycythemia Vera (PV) Trial in Japan (P1101, Low-dose aspirin, Phlebotomy)

Completed
  • Polycythemia Vera (PV)
  • Toon-shi, Ehime, Japan
  • +7 more
Dec 8, 2021

Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Primary Myelofibrosis, Secondary Myelofibrosis Trial in Houston

Completed
  • Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
May 27, 2022

Myelofibrosis Trial (Momelotinib)

Available
  • Myelofibrosis
  • (no location specified)
Oct 12, 2022

Phlebotomy Dependent Polycythemia Vera Trial in Canada, United Kingdom, United States (IONIS-TMPRSS6-LRx)

Recruiting
  • Phlebotomy Dependent Polycythemia Vera
  • Orange, California
  • +4 more
Aug 1, 2022

Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, ET-MF Trial in New York (Canakinumab)

Recruiting
  • Primary Myelofibrosis
  • +4 more
  • New York, New York
    Ruttenberg Treatment Center
Jul 18, 2022

Polycythemia Vera Trial in Italy (AOP2014, Phlebotomies, ASA)

Active, not recruiting
  • Polycythemia Vera
  • San Giovanni Rotondo, (FG) Puglia, Italy
  • +22 more
Jan 10, 2023

Primary Myelofibrosis Trial in Japan (Fedratinib)

Recruiting
  • Primary Myelofibrosis
  • Suwa, Nagano, Japan
  • +25 more
Jan 18, 2023

Polycythemia Vera Trial in Italy

Recruiting
  • Polycythemia Vera
    • Reggio Calabria, Calabria, Italy
    • +21 more
    Nov 10, 2023

    Hematocrit to Hemoglobin Ratio and Red Blood Cell Distribution

    Recruiting
    • Polycythemia Vera
      • Sohag, Egypt
        Faculty of Medicine
      Aug 12, 2023

      Polycythemia Vera Trial in China (Ropeginterferon alfa-2b)

      Active, not recruiting
      • Polycythemia Vera
      • Ropeginterferon alfa-2b
      • Beijing, China
      • +13 more
      Aug 1, 2022

      Chronic Myelomonocytic Leukemia, Chronic Myeloid Leukemia, Polycythemia Vera Trial in Houston (Imatinib Mesylate (Gleevec))

      Completed
      Has Results
      • Chronic Myelomonocytic Leukemia
      • +4 more
      • Imatinib Mesylate (Gleevec)
      • Houston, Texas
        UT MD Anderson Cancer Center
      Dec 7, 2021

      Myelofibrosis Trial in Canton (Jaktinib Hydrochloride Tablet)

      Recruiting
      • Myelofibrosis
      • Jaktinib Hydrochloride Tablet
      • Canton, Ohio
        Site 01
      Aug 18, 2022

      Primary Myelofibrosis, Post-Polycythemia Vera, Post-Essential Thrombocytopenia Trial in United States (Panobinostat)

      Terminated
      Has Results
      • Primary Myelofibrosis
      • +2 more
      • Scottsdale, Arizona
      • +8 more
      Jul 9, 2021